Cite
HARVARD Citation
Boyapati, A. et al. (2016). Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY. Arthritis research & therapy. 18 (1), pp. 1-12. [Online].